IF anti-IL-11 neutralizing antibody (X203 or equivalent, subcutaneous, 20 mg/kg bi-weekly — consistent with Widjaja et al. 2024 dosing in aged mice) is administered to 18–24-month-old male and female C57BL/6J mice carrying a p16-luciferase or p16-tdTomato reporter transgene,
THEN a statistically significant reduction (≥30%) in p16INK4a+ cell counts across liver, kidney, lung, and adipose tissue — quantified by flow cytometry of dissociated tissue and validated by in vivo bioluminescent imaging — will be observed relative to vehicle-treated aged controls, with this reduction exceeding what is achievable by a benchmark senomorphic agent (MDM2 inhibitor nutlin-3a at senomorphic dose) that suppresses SASP without reducing senescent cell number,
BECAUSE the following mechanistic chain operates:
-
Senescent cells in aged tissues produce IL-11 as part of the SASP, creating an autocrine/paracrine IL-11→gp130→ERK signaling loop [SPECULATIVE — no direct DOI in Evidence Set for IL-11 as autocrine SASP factor; supported by the general SCAP framework described in the translational senescence review establishing that pro-survival pathways can be identified by transcriptional profiling of senescent cells] (Senescent Cell Anti-Apoptotic Pathways framework)(https://doi.org/10.1016/j.ebiom.2017.04.013).
-
This ERK activation downstream of IL-11/gp130 feeds directly into RAS signaling, which has been mechanistically demonstrated to sustain oxylipin biosynthesis — specifically the dihomo-15d-PGJ2/PGD2-derived lipid axis — creating a positive feedback loop that reinforces both the sen





























